Contact this trialFirst, we need to learn more about you.
HIF2α Inhibitor
Oral NKT2152 for Kidney Cancer
Recruiting1 awardPhase 1 & 2
Iowa City, Iowa
This trial will test a new drug for kidney cancer. The first part will find the best dose of the drug, and the second part will see if it works.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.